Previous 10 | Next 10 |
DUBLIN, Ireland, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that the U.S. Food and Drug Administration (FDA) notified the company that the review of the New Drug Application (ND...
LM Funding America (NASDAQ:LMFA) +45%. Sonoma Pharmaceuticals SNOA +31% with extended approval for Nanocyn in Australia ABVC BioPharma (NASDAQ:ABVC) +23%. Companhia Brasileira de Distribuicao (NYSE:CBD) +14%. Avadel Pharmaceuticals (NASDAQ:AVDL) +13%. Checkmate Pharmaceuticals CMPI&...
Gainers: 23andMe Holding (NASDAQ:ME) +13%. Performant Financial Corporation (NASDAQ:PFMT) +4%. G1 Therapeutics (NASDAQ:GTHX) +3%. Kala Pharmaceuticals (NASDAQ:KALA) +3%. Avadel Pharmaceuticals (NASDAQ:AVDL) +3%. Losers: Duck Creek Technologies DCT -10%. Corsair Gaming CRS...
Gainers: Hyzon Motors HYZN +5%. Avadel Pharmaceuticals (NASDAQ:AVDL) +4%. Allogene Therapeutics (NASDAQ:ALLO) +4%. Latch (NASDAQ:LTCH) +2%. Old National Bancorp (NASDAQ:ONB) +2%. Losers: Xiaobai Maimai (NASDAQ:HX) -4%. Clarus Therapeutics Holdings (NASDAQ:CRXT) -4%. Relay Thera...
Protagonist Therapeutics (NASDAQ:PTGX) +89% after FDA removes clinical hold on rusfertide program Flexion Therapeutics (NASDAQ:FLXN) +73% Pacira Therapeutics acquires Flexion Therapeutics for $8.50 per share in cash plus one CVR Adamas Pharmaceuticals (NASDAQ:ADMS) +7...
You can read full article here: For further details see: Wall Street Breakfast: The Week Ahead (Podcast)
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The Q3 earnings season begins next week with companies in the S&P 500 Index looking to match the 28.3% profit growth...
Biogen (NASDAQ:BIIB) and Sage Therapeutics (NASDAQ:SAGE) have been granted buy ratings at Needham as the firm initiated the coverage on companies focused on neurological diseases despite hurdles for therapeutic development in an area with a significant unmet need. For Biogen (BIIB), the analy...
MEDIROM Healthcare Technologies (NASDAQ:MRM) +77% on deal for ZACC Kabushiki Kaisha Digital Brands (NASDAQ:DBGI) +27%. TransCode Therapeutics (NASDAQ:RNAZ) +15% announces publication in cancer nanotechnology of preclinical data supporting therapeutic potential of TTX-MC138 in m...
DUBLIN, Ireland, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced its support of the third annual World Narcolepsy Day on Wednesday, September 22. FT218 is the Company’s curre...
News, Short Squeeze, Breakout and More Instantly...
Avadel Pharmaceuticals plc Company Name:
AVDL Stock Symbol:
NASDAQ Market:
Avadel Pharmaceuticals plc Website:
DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell US Ind...
2024-05-29 06:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– 11 accepted abstracts, including new data reiterating satisfaction, preference and clinical benefit of LUMRYZ – – Presentations highlight Avadel’s continued commitment to address gaps in narcolepsy care – DUBLIN, May 22, 2024 (GLOBE NEWSWIRE) -...